Protalix BioTherapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2016 | 8.6% | -355.7% | -314.9% |
| FY2017 | 19.3% | -166.0% | -401.2% |
| FY2018 | 72.1% | -58.0% | -79.5% |
| FY2019 | 80.0% | -19.7% | -33.5% |
| FY2020 | 82.7% | 4.3% | -10.4% |
| FY2021 | 57.4% | -53.3% | -71.9% |
| FY2022 | 58.9% | -27.3% | -31.3% |
| FY2023 | 65.9% | 15.5% | 12.3% |
| FY2024 | 54.5% | 7.3% | 5.5% |
| FY2025 | 48.8% | -10.4% | -12.5% |